Related Experiment Video
Updated: Sep 19, 2025
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease
Faizan Mazhar1, Edouard L Fu2, Anne-Laure Faucon1
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Insights
Elevated C-reactive protein (CRP) levels in adults with atherosclerotic cardiovascular disease (ASCVD) are linked to increased risks of adverse kidney outcomes, including acute kidney injury (AKI) and kidney failure.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Inflammation Research
Background:
- Inflammasome activation plays a role in atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD).
- The association between C-reactive protein (CRP), a marker of systemic inflammation, and kidney outcomes in ASCVD patients requires further investigation.
Purpose of the Study:
- To investigate the association between systemic inflammation, measured by CRP, and adverse kidney outcomes in adults with ASCVD.
Main Methods:
- Retrospective cohort study of 83,928 adults with ASCVD in Stockholm, Sweden (2007-2021).
- Systemic inflammation assessed by geometric mean of serum CRP levels, excluding acute inflammatory processes.
- Cause-specific Cox proportional hazards regression used to analyze associations with composite kidney outcomes and acute kidney injury (AKI).
Main Results:
- 59% of participants exhibited systemic inflammation (CRP ≥ 2 mg/L).
- Higher CRP levels were significantly associated with increased risks of both composite kidney outcomes (sustained eGFR decrease or kidney failure) and AKI.
- Adjusted hazard ratios for the composite kidney outcome increased with higher CRP categories, ranging from 1.16 to 1.35 compared to CRP ≤ 1 mg/L.
Conclusions:
- In adults with ASCVD, elevated CRP levels are associated with a higher risk of adverse kidney outcomes.
- Findings suggest systemic inflammation is a significant factor in kidney disease progression within this population.
- Limitations include potential unmeasured confounding inherent to observational studies.
Rationale & Objective:
Inflammasome activation is involved in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD). This study investigated whether systemic inflammation, measured by C-reactive protein (CRP), is associated with adverse kidney outcomes in adults with ASCVD.
Study Design:
Retrospective cohort study.
Setting & Participants:
83,928 adults with ASCVD in Stockholm, Sweden, who underwent routine CRP testing between 2007 and 2021.
Exposure(S):
CRP was defined as the geometric mean of serum CRP levels within a 3-month ascertainment window, excluding CRP values potentially associated with an acute inflammatory process.
Outcome(S):
Acute kidney injury (AKI; based on diagnosis code or Kidney Disease: Improving Global Outcomes [KDIGO] serum creatinine criteria) and a composite kidney outcome defined as a sustained>30% decrease in estimated glomerular filtration rate or kidney failure.
Analytical Approach:
Cause-specific Cox proportional hazards regression.
Results:
54% of the cohort was male, with a mean age of 71 years, and 59% of participants had systemic inflammation (CRP≥2mg/L). During a median follow-up of 6.4 years (IQR, 3.1-9.8 years), 8,371 kidney events, 10,757 AKI events, and 24,954 deaths were recorded. Compared with CRP<1mg/L, higher CRP categories were associated with increased risks of both outcomes. Compared with a CRP of≤1mg/L, the adjusted HRs for the composite kidney outcome were 1.16 (95% CI, 1.09-1.23) for CRP>1-3mg/L, 1.24 (1.17-1.32) for CRP>3-10mg/L, and 1.35 (1.25-1.46) for CRP>10-20mg/L. For AKI, the HRs were 1.18 (1.12-1.25), 1.34 (1.27-1.42), and 1.37 (1.28-1.47), respectively.
Limitations:
Unmeasured confounding inherent to observational studies.
Conclusions:
In this large cohort of adults with ASCVD, increased CRP levels were associated with higher risks of adverse kidney outcomes.
Plain-Language Summary:
Inconsistent evidence exists regarding the association between the circulating blood marker of inflammation C-reactive protein (CRP) and kidney outcomes. We conducted an observational study in more than 83,000 adults with atherosclerotic cardiovascular disease undergoing routine care. The study showed that CRP levels were higher in participants with lower levels of kidney function and that CRP was associated with more rapid declines in kidney function over time as well as a greater risk of acute kidney injury.
More Related Videos
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
01:29Acute Kidney Injury II: Pathophysiology
01:24Nephrotic Syndrome I : Introduction
01:30Coronary Artery Disease I: Introduction
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:29Acute Kidney Injury III: Clinical Manifestations